PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/3047/6/18
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
A Menarini
An anonymous contactable UK health professional complained about a Migard (frovatriptan) advertisement on the BMJ website.The ad did not include prescribing information; instead it provided a singl…
Clauses: NONE
🔒 Subscribers only
AUTH/3039/5/18
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Dr Falk
Tillotts complained about a Dr Falk Pharma UK Ltd advertisement for Budenofalk (budesonide) (ref DrF17/159).Budenofalk existed as multiple products sharing the root name: 3mg gastro-resistant capsu…
Clauses: NONE
🔒 Subscribers only
AUTH/3037/4/18
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shield Therapeutics
An anonymous UK health professional complained about content on Shield Therapeutics’ corporate website relating to Feraccru (ferric maltol) and pipeline products PT20, PT30 and PT40.The complaina…
Clauses: NONE
🔒 Subscribers only
AUTH/3036/4/18
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Concordia
An anonymous contactable UK health professional complained about a journal advertisement for Morphgesic SR 10mg modified release morphine sulphate (ref Con/MOR/PM/0021) published in Pulse, April 20…
Clauses: NONE
🔒 Subscribers only
AUTH/3033/4/18
HCP Hospitality & Meetings Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Boehringer Ingelheim Limited and Eli Lilly and Company Limited (the Alliance) complained about Novo Nordisk’s promotion of Victoza (liraglutide).Material: an exhibition panel (ref UK/VT/0318/0108…
Clauses: NONE
🔒 Subscribers only
AUTH/3017/2/18
HCP Hospitality & Meetings Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Celgene ‘meetings in a box’ materials
An anonymous, contactable complainant alleged Celgene UK used “meetings in a box” materials for Otezla (apremilast) without proper certification/approval and that senior leadership tried to rep…
Clauses: NONE
🔒 Subscribers only
AUTH/3012/1/18
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Pierre Fabre
Pierre Fabre made a voluntary admission of Code breaches relating to materials for Toviaz (fesoterodine) used at an April 2017 cycle meeting and then emailed to representatives (email dated 2 May 2…
Clauses: NONE
🔒 Subscribers only
AUTH/3096/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
AUTH/3096/9/18 Director v Shire
Clauses: NONE
🔒 Subscribers only
AUTH/3135/12/18
Data & Publications Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Astellas breached ABPI Code over unqualified ‘more patients stay on Betmiga’ persistence claim in Pu
A concerned health professional complained about a Betmiga (mirabegron) advertisement (ref BET18035UKa) published in the December 2018 edition of Pulse.The ad’s headline claim stated: “More OAB…
Clauses: 3.2,4.1
🔒 Subscribers only
AUTH/3098/9/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
A Menarini
Clauses: NONE
🔒 Subscribers only
AUTH/3090/9/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Novartis
The Director took up a BMJ paper (Goldacre et al, 12 Sept 2018) assessing whether sponsors posted trial results to the EU Clinical Trials Register (EUCTR) within 12 months of completion (final comp…
Clauses: NONE
🔒 Subscribers only
AUTH/3093/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Roche
The Director opened a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted due trial results to the EU Clinical Trials Register (EUCTR) within…
Clauses: NONE
🔒 Subscribers only
AUTH/3134/12/18
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Shield
An anonymous complainant (described as a concerned UK health professional) challenged content in the FAQs on Shield’s Feraccru (ferric maltol) website for health professionals.FAQ 1 (Hb): The sit…
Clauses: NONE
🔒 Subscribers only
AUTH/3088/9/18
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Ipsen
The PMCPA Director initiated a complaint (under Paragraph 5.1) after a BMJ paper (Goldacre et al, published online 12 September 2018) assessed whether sponsors posted due trial results to the EU Cl…
Clauses: NONE
🔒 Subscribers only
AUTH/3081/9/18
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Astellas UK
Clauses: NONE
🔒 Subscribers only
AUTH/3035/4/18
Off-label Promotion Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer breached ABPI Code over ambiguous Xarelto renal impairment claim implying use “with confidence
An anonymous UK health professional complained about a Bayer Xarelto (rivaroxaban) advertisement (ref UKXAR01180037d) placed in Pulse, April 2018.Headline claim: “Xarelto Protects Your High-Risk …
Clauses: 4.1,9.1
🔒 Subscribers only
AUTH/3086/9/18
Data & Publications Upheld 🏥 Other ▶ Video 🎙 Podcast
Merck Sharp & Dohme
Not stated (no case narrative provided in CASE_TEXT).
🔒 Subscribers only
AUTH/3085/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Biogen
The PMCPA Director opened a complaint (under Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted results to the EU Clinical Trials Register (EUCTR) with…
Clauses: NONE
🔒 Subscribers only
AUTH/3080/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Takeda
The PMCPA Director opened a complaint (under Paragraph 5.1 of the Constitution and Procedure) after a BMJ paper (Goldacre et al, published 12 Sept 2018) assessed whether sponsors posted due results…
Clauses: NONE
🔒 Subscribers only
AUTH/3078/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Amgen
Clauses: NONE
🔒 Subscribers only
AUTH/3029/4/18
HCP Hospitality & Meetings Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
GW Pharmaceuticals
A contactable complainant alleged that a third-party employee acting for GW Pharmaceuticals took a named health professional to lunch at a local café and that the discussion was unrelated to epile…
Clauses: NONE
🔒 Subscribers only
AUTH/3034/4/18
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca ‘Fixing Dad’ HCP webpage ruled promotional in context—missing prescribing information
An anonymous UK health professional complained about a ‘Fixing Dad’ video trailer embedded on AstraZeneca UK’s Medicines website within the diabetes section.The page invited HCPs to arrange a…
Clauses: NONE
🔒 Subscribers only
AUTH/3069/9/18
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
The PMCPA Director initiated a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted results to the EU Clinical Trials Register (EUCTR) within …
Clauses: NONE
🔒 Subscribers only
AUTH/3038/4/18
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis employee’s LinkedIn activity ruled promotional
An anonymous, contactable UK health professional complained about a named Novartis employee’s activity on their personal LinkedIn account.The activity related to two prescription-only medicines (…
Clauses: NONE
← Prev 25 26 27 28 29 30 31 Next → Page 28 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews